TUT4 and prostate carcinoma: Contrary to a previous study in cervical-derived HeLa cells, which concluded that the functional activity of both TUT4 and TUT7 is vital for cell viability (Lim et al. 2014), our data show that TUT4 and TUT7 are not required for viability in the prostate cancer cell line DU145 and the ovarian cancer cell line IGROV1.